Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Epagny Metz- Tessy
Clinical trial register · France

Clinical Trials in Epagny Metz- Tessy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 2820 Lyon 1390 Bordeaux 1389 Marseille 1285 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Site location
Paris2820 Lyon1390 Bordeaux1389 Marseille1285 Lille1283
All 803 locations
Target enrolment
to

Trials with a site in Epagny Metz- Tessy

10 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Boehringer Ingelheim
Phase 3
448
Bordeaux, Brest, Caen, Epagny Metz-Tessy, Marseille, Nantes, Paris, Rennes
2026-07-27
Recruiting
Pfizer
Phase 2/3
1,156
Montpellier, Paris, Epagny Metz-Tessy, Lyon
2026-02-11
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Avignon, Epagny Metz-Tessy, Le Mans
2025-11-28
Not yet open
Hospices Civils de Lyon
Not applicable
316
Angers, Bordeaux, Epagny METZ Tessy, La Tronche, Lyon, Pierre-Benité, Toulon
2025-10-01
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Active, closed
AstraZeneca
Phase 3
5,511
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Epagny Metz-Tessy, Lille, Lyon
2023-10-05
Recruiting
University Hospital, Toulouse
Not applicable
100
Amiens, Caen, Dijon, Epagny Metz- Tessy, Lille, Lyon, Montpellier, Paris
2023-09-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Marseille, Brest, Epagny Metz Tessy, Valenciennes, Bobigny, Amiens, Toulon, La Roche-sur-Yon
2020-07-06
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Amiens, Angers, Cesson-Sévigné, Chalon-sur-Saône, Corbeil-Essonnes, Créteil, Dijon, Epagny-Metz-Tessy
2019-12-12
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 October 2026. https://priyalifescience.com/clinical-trials-france/city/epagny-metz-tessy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Epagny Metz- Tessy.

How many clinical trials are recruiting in Epagny Metz- Tessy?

6 of the 10 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Epagny Metz- Tessy), 10 studies
PhaseStudiesRecruitingShare
Phase 34240%
Not applicable2120%
Phase 2/32220%
Observational1010%
Phase 21110%

Most active sponsors

Lead sponsors with the most studies (Epagny Metz- Tessy)
Lead sponsorStudiesRecruiting
Eli Lilly and Company22
AbbVie11
AstraZeneca10
Boehringer Ingelheim11
Hospices Civils de Lyon10
Merck Sharp & Dohme LLC10
Pfizer11
RECORDATI GROUP10
University Hospital, Toulouse11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.